AEON Biopharma (AEON)

• Market cap: $19M
• 1 day: -9.91%
• 5 days: -19.82%
• 1 month: -23.71%
• 3 months: -25.61%
• 6 months: -17.06%
• Year to date: -34.99%
• 1 year: 46.34%
• 5 years: -99.9%
• 10 years: -99.9%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

Employees: 8